Reported in CVID patients are mutations in the components of the CD19 complex (CD19, CD81, and CD21) [28, 29, 31, 57] as well as in membranous costimulatory molecules such as CD20 in CVID [26, 58–61]. The gene discussed is CR2; the disease is common variable immunodeficiency.